P-161 - PHARMACOKINETICS (PK) OF SACITUZUMAB GOVITECAN (SG), A TROP-2-DIRECTED ANTIBODY-TOPOISOMERASE I INHIBITOR SN-38 DRUG-CONJUGATE, IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS.
I. Singh1, A. Sathe1, P. Singh1, F. Boakye-Agyeman2, L. Tatalick3, T. Goswami4, S. Girish1, A. Othman1; 1Gilead Sciences, Inc., Foster City, CA, USA, 2Certara, Princeton, NJ, USA, 3Laurie Tatalick Consulting, PLLC, Redmond, WA, USA, 4Gilead Sciences, Inc., Morris Plains, NJ, USA.